Crossref
EE364 COST-BENEFIT ANALYSIS OF TUMOR TREATING FIELDS PLUS RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
Value in Health · 2026-06 · 29 (6) · S132
DOI: 10.1016/j.jval.2026.03.658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Greg Guzauskas und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Guzauskas, G., Guzman, J. F. N. D. R., & Wang, B. (2026). EE364 COST-BENEFIT ANALYSIS OF TUMOR TREATING FIELDS PLUS RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER. Value in Health, 29(6), S132. https://doi.org/10.1016/j.jval.2026.03.658
Vancouver
Guzauskas G, Guzman JFNDR, Wang B. EE364 COST-BENEFIT ANALYSIS OF TUMOR TREATING FIELDS PLUS RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER. Value in Health. 2026;29(6):S132. doi:10.1016/j.jval.2026.03.658
BibTeX
@article{Guzauskas2026,
author = {Guzauskas, Greg and Guzman, Jorge F. Nino de Rivera and Wang, Bruce},
title = {EE364 COST-BENEFIT ANALYSIS OF TUMOR TREATING FIELDS PLUS RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S132},
doi = {10.1016/j.jval.2026.03.658}
}
EUVIMED